                         SEQUENCE LISTING

<110>  CohBar Inc.
 
<120>  THERAPEUTIC PEPTIDES

<130>  32701/54002A

<150>  62/887,101
<151>  2019-08-15

<150>  62/887,265
<151>  2019-08-15

<150>  62/887,245
<151>  2019-08-15

<150>  62/887,043
<151>  2019-08-15

<150>  62/887,018
<151>  2019-08-15

<160>  37    

<170>  PatentIn version 3.5

<210>  1
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is absent or if present is an amino acid having a non-polar 
       side chain

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<400>  1

Xaa Leu Ala Val Arg Arg Thr Ala Arg Ala Xaa Xaa 
1               5                   10          


<210>  2
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  2

Met Leu Ala Val Arg Arg Thr Ala Arg Ala Ile Gly 
1               5                   10          


<210>  3
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  3

Leu Ala Val Arg Arg Thr Ala Arg Ala Ile Gly 
1               5                   10      


<210>  4
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  4

Leu Ala Val Arg Arg Thr Ala Arg Ala Ile 
1               5                   10  


<210>  5
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  D-Ala

<400>  5

Leu Ala Val Arg Arg Thr Ala Arg Ala Ala 
1               5                   10  


<210>  6
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is absent or if present is an amino acid having a polar side 
       chain or non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is absent or if present is an amino acid having a polar side 
       chain or non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is absent or if present is an amino acid having a polar side 
       chain or non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is absent or if present is an amino acid having a polar side 
       chain or non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is an amino acid having a polar side chain or non-polar side 
       chain

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is an amino acid having a polar side chain or non-polar side 
       chain

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is absent or if present is an amino acid having a non-polar 
       side chain

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is absent or if present is an amino acid having a non-polar 
       side chain

<400>  6

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Ile Leu Thr Asn Pro Val Leu Xaa Trp 
1               5                   10                  15      


Val Xaa Xaa 
            


<210>  7
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  7

Met Arg Leu Pro Gly Ser Ala Ile Leu Thr Asn Pro Val Leu Gly Trp 
1               5                   10                  15      


Val Trp Val 
            


<210>  8
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  8

Arg Leu Pro Gly Ser Ala Ile Leu Thr Asn Pro Val Leu Gly Trp Val 
1               5                   10                  15      


Trp Val 
        


<210>  9
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-Ala

<400>  9

Arg Leu Pro Gly Ser Ala Ile Leu Thr Asn Pro Val Leu Gly Trp Val 
1               5                   10                  15      


Trp Val 
        


<210>  10
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-Ala

<400>  10

Arg Leu Pro Gly Ser Ala Ile Leu Thr Asn Pro Val Leu Gly Trp Val 
1               5                   10                  15      


<210>  11
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<400>  11

Arg Leu Pro Gly Ser Ala Ile Leu Thr Asn Pro Val Leu Ala Trp Val 
1               5                   10                  15      


Trp Val 
        


<210>  12
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-Ala

<400>  12

Arg Leu Pro Ala Ser Asn Ile Leu Thr Asn Pro Val Leu Ala Trp Val 
1               5                   10                  15      


Trp Val 
        


<210>  13
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-Ala

<400>  13

Arg Leu Pro Gly Ser Ala Ile Leu Thr Asn Pro Val Leu Gly Trp Val 
1               5                   10                  15      


Trp 
    


<210>  14
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  14

Met Arg Leu Pro Gly Pro Ala Ile Leu Thr Asn Pro Val Leu Gly Trp 
1               5                   10                  15      


Val Trp Val 
            


<210>  15
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  D-Ala

<400>  15

Leu Pro Gly Ser Ala Ile Leu Thr Asn Pro Val Leu Gly Trp Val Trp 
1               5                   10                  15      


Val 
    


<210>  16
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Ala

<400>  16

Pro Gly Ser Ala Ile Leu Thr Asn Pro Val Leu Gly Trp Val Trp Val 
1               5                   10                  15      


<210>  17
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  D-Ala

<400>  17

Gly Ser Ala Ile Leu Thr Asn Pro Val Leu Gly Trp Val Trp Val 
1               5                   10                  15  


<210>  18
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Ala

<400>  18

Ser Ala Ile Leu Thr Asn Pro Val Leu Gly Trp Val Trp Val 
1               5                   10                  


<210>  19
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is absent or an amino acid having a non-polar or a polar side
       chain

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is absent or an amino acid having a polar side chain;Xaa is 
       absent if Xaa1 is absent or if Xaa1 has a polar side chain

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Xaa is an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is absent or an amino acid having a polar side chain

<400>  19

Xaa Xaa Phe Gln Lys Thr His Asn Leu Asn Gln His Asn His Pro Gln 
1               5                   10                  15      


Xaa Asn Xaa 
            


<210>  20
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  20

Met Thr Phe Gln Lys Thr His Asn Leu Asn Gln His Asn His Pro Gln 
1               5                   10                  15      


Pro Asn Tyr 
            


<210>  21
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  21

Thr Phe Gln Lys Thr His Asn Leu Asn Gln His Asn His Pro Gln Pro 
1               5                   10                  15      


Asn Tyr 
        


<210>  22
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Ala

<400>  22

Ala Phe Gln Lys Thr His Asn Leu Asn Gln His Asn His Pro Gln Pro 
1               5                   10                  15      


Asn Tyr 
        


<210>  23
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  D-Ala

<400>  23

Ala Phe Gln Lys Thr His Asn Leu Asn Gln His Asn His Pro Gln Ala 
1               5                   10                  15      


Asn 
    


<210>  24
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<220>
<221>  misc_feature
<222>  (19)..(19)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<400>  24

Xaa Xaa Val Lys Ala Pro Leu Ser Glu Gly Gly His Pro Trp Gly Arg 
1               5                   10                  15      


Glu Gly Xaa 
            


<210>  25
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  25

Met Val Val Lys Gly Pro Leu Ser Glu Gly Gly His Pro Trp Gly Arg 
1               5                   10                  15      


Glu Gly Ile 
            


<210>  26
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  26

Val Val Lys Gly Pro Leu Ser Glu Gly Gly His Pro Trp Gly Arg Glu 
1               5                   10                  15      


Gly Ile 
        


<210>  27
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  27

Val Val Lys Gly Pro Leu Ser Glu Gly Gly His Pro Trp Gly Arg Glu 
1               5                   10                  15      


Gly 
    


<210>  28
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  28

Val Lys Ala Pro Leu Ser Glu Gly Gly His Pro Trp Gly Arg Glu Gly 
1               5                   10                  15      


<210>  29
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<400>  29

Xaa Trp Xaa Ile Asp Glu Lys Ala Val Glu Xaa Ser Gly Glu 
1               5                   10                  


<210>  30
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  30

Met Trp Ala Ile Asp Glu Lys Ala Val Glu Ala Ser Gly Glu 
1               5                   10                  


<210>  31
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  31

Trp Ala Ile Asp Glu Lys Ala Val Glu Ala Ser Gly Glu 
1               5                   10              


<210>  32
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Ala

<400>  32

Trp Ala Ile Asp Glu Lys Ala Val Glu Ala Ser Gly Glu 
1               5                   10              


<210>  33
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  D-Ala

<400>  33

Trp Ala Ile Asp Glu Lys Ala Val Glu Ala Ser Gly Glu 
1               5                   10              


<210>  34
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  34

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala 
1               5                   10      


<210>  35
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  35

Tyr Gly Arg Lys Lys Arg Arg 
1               5           


<210>  36
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  36

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210>  37
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  37

Arg Arg Gln Arg Arg 
1               5   


